These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 31305674)

  • 1. Erratum: Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia: Erratum.
    Medicine (Baltimore); 2017 Jun; 96(23):e7231. PubMed ID: 31305674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Medicine, Volume 95, Issue 23: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(28):e0916. PubMed ID: 31265603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.
    Zhang S; Du T; Li M; Lu H; Lin X; Yu X
    Medicine (Baltimore); 2017 Mar; 96(12):e6381. PubMed ID: 28328829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Low serum levels of uric acid and albumin in patients with GuillainBarre syndrome: Erratum.
    Medicine (Baltimore); 2017 Jun; 96(25):e7318. PubMed ID: 31305683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
    Saudi J Gastroenterol; 2018; 24(4):255. PubMed ID: 30052239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum to "Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease".
    Yang F; Zhou J; Su B; Zhang Q; Luo X; Wang F; Huang J; Huang W
    Evid Based Complement Alternat Med; 2022; 2022():9782896. PubMed ID: 35996404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bariatric surgeries on nonalcoholic fatty liver disease: Erratum.
    Saudi J Gastroenterol; 2015; 21(5):341. PubMed ID: 26458864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum to "Low-molecular weight oligosaccharides from gum tragacanth (
    Food Sci Nutr; 2023 Jun; 11(6):3616. PubMed ID: 37324911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.
    Giles DA; Moreno-Fernandez ME; Stankiewicz TE; Graspeuntner S; Cappelletti M; Wu D; Mukherjee R; Chan CC; Lawson MJ; Klarquist J; Sünderhauf A; Softic S; Kahn CR; Stemmer K; Iwakura Y; Aronow BJ; Karns R; Steinbrecher KA; Karp CL; Sheridan R; Shanmukhappa SK; Reynaud D; Haslam DB; Sina C; Rupp J; Hogan SP; Divanovic S
    Nat Med; 2017 Oct; 23(10):1241. PubMed ID: 28985207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum].
    Diabetes Metab Syndr Obes; 2023; 16():2833-2834. PubMed ID: 37736329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Resting and Exercise Energy Metabolism After Liver Transplantation for Nonalcoholic Steatohepatitis: Erratum.
    Transplant Direct; 2017 Nov; 3(11):1. PubMed ID: 29184904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Sex-Based Differences and Risk Factors for Comorbid Nonalcoholic Fatty Liver Disease in Patients with Bipolar Disorder: A Cross-Sectional Retrospective Study [Corrigendum].
    Diabetes Metab Syndr Obes; 2024; 17():1335-1336. PubMed ID: 38525160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components.
    Kim S; Choi J; Kim M
    Hepatol Int; 2013 Jun; 7(2):586-91. PubMed ID: 26201791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum.
    Jin K; Liu Y; Shi Y; Zhang H; Sun Y; Zhangyuan G; Wang F; Yu W; Wang J; Tao X; Chen X; Zhang W; Sun B
    Theranostics; 2022; 12(8):3604-3606. PubMed ID: 35664079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum.
    Sci Technol Adv Mater; 2016; 17(1):188. PubMed ID: 27889790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
    Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
    Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum to:
    Pilot and Feasibility Studies
    Pilot Feasibility Stud; 2017; 3():48. PubMed ID: 29123916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Design, Implementation, and Evaluation of the Adolescents and Surveillance System for the Obesity Prevention Project: Erratum.
    Medicine (Baltimore); 2016 Apr; 95(17):e77f8. PubMed ID: 31265564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.